Oncology

Latest News

Diabetes monitoring | Image credit: abidika - stock.adobe.com

New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

April 23rd 2025

A new study has found increased risks for liver, pancreatic, and bowel cancers following a new diagnosis of type 2 diabetes—but not all obesity-related cancers show a link.

Vitamin D | Image credit: Galina Zhigalova - stock.adobe.com

Vitamin D’s Role in Colorectal Cancer Prevention, Immune Health

By Pearl Steinzor

April 23rd 2025

The study highlighted symptom patterns in the short-term preceding ED visits and unplanned hospitalizations using a previously validated natural language processing a pipeline. | Image credit: Tyler Olson - stock.adobe.com

Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities

By Rose McNulty

April 22nd 2025

With Thyme Care Partnership, AON Achieves $6M in Savings in EOM’s First Performance Period

By Mary Caffrey

April 22nd 2025

Within 5 years, the risk of SCC in particular was heightened among patients with MMP. | Image credit: wavebreak3 - stock.adobe.com

Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers

By AJMC Contributor

April 21st 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

May 17th 2011

Impact of New Drugs and Biologics on Colorectal Cancer Treatment and Costs

Pinar Karaca-Mandic, PhD Jeffrey S. McCullough, PhD Mustaqeem A. Siddiqui, MBBS Holly Van Houten, BA Nilay D. Shah, PhD

We measured the financial consequences of new CRC treatment regimens. New regimens have increased cost directly through price and indirectly through nonstandard and second-line regimen use.

May 16th 2011

Trying Something New: Episode Payments for Cancer Therapy

Lee N. Newcomer, MD, MHA

Healthcare coverage is simply unaffordable for too many people. It will only become affordable with radical changes in payment incentives and elimination of care that doesn%u2019t really matter.

May 16th 2011

Impact of Clinical Oral Chemotherapy Program on Wastage and Hospitalizations

Nikhil Khandelwal, PhD, BPharm Ian Duncan, FSA, FIA, FCIA, MAAA Tamim Ahmed, PhD, MBA Elan Rubinstein, MPH, PharmD Cheryl Pegus, MPH, MD

An oral chemotherapy cycle management program offers clinical support, reduces medication wastage, and provides management of adverse effects to realize cost savings for payers and patients.

May 15th 2011

Are We Winning the War on Cancer?

Ted Okon, MBA Lee Schwartzberg, MD, FACP

With an increasing demand for cancer care driven by the demographics of the aging population far outpacing the supply of oncologists, and the ongoing transformation of the reimbursement system, the challenges facing oncology are formidable.

May 15th 2011

Genomic Testing and Therapies for Breast Cancer in Clinical Practice

Jennifer S. Haas, MD, MSPH Kathryn A. Phillips, PhD Su-Ying Liang, PhD Michael J. Hassett, MD, MPH Carol Keohane, BSN, RN Elena B. Elkin, PhD Joanne Armstrong, MD, MPH Michele Toscano, MS

Despite almost universal testing for human-epidermal-growth-factor-receptor-2 (HER2), many women with a HER2-positive cancer may not receive trastuzumab. Fewer women received the newer gene-expression-profile (GEP) test.

May 14th 2011

Oncology Management Programs for Payers and Physicians

Dawn Holcombe, FACMPE, MBA

Evaluating current models and diagnosing successful strategies for payers and physicians.

May 13th 2011

Journey Forward: The New Face of Cancer Survivorship Care

Jennifer Hausman, MPH Patricia A. Ganz, MD Thomas P. Sellers, MPA Joel Rosenquist, MPA

WellPoint, UCLA's Jonsson Comprehensive Cancer Center, the National Coalition for Cancer Survivorship (NCCS) and Genentech collaborated to develop Journey Forward, a first-of-its-kind program for coordinating post-treatment care.

May 12th 2011

US Insurance Program's Experience With a Multigene Assay for Early-Stage Breast Cancer

John Hornberger, MD, MS Rebecca Chien, BA Katie Krebs, MHA Louis Hochheiser, MD

This study presents Humana's experience with a multigene breast cancer assay and provides an analysis of the clinical utility and economics of this technology.

May 11th 2011

Effect of the Pay-for-Performance Program for Breast Cancer Care in Taiwan

Raymond N.C. Kuo, PhD Kuo-Piao Chung, PhD Mei-Shu Lai, MD, PhD

The pay-for-performance program for breast cancer care had a positive impact on breast cancer outcome in Taiwan. Enrollees received better quality care and had better outcome.

April 28th 2011

Oncology Pharmacy: Strategies in the Managed Care Setting

Pre-conference program provided recommendations for oncology pharmacy management strategies.

April 19th 2011

Primary Care and Communication in Shared Cancer Care: A Qualitative Study

Yvonne H. Sada, MD Richard L. Street Jr, PhD Hardeep Singh, MD, MPH Rachel E. Shada, MHR Aanand D. Naik, MD

This qualitative study assesses patient, PCP, and oncologist views on primary care roles in shared cancer care, as well as patterns of communication between physicians.

February 14th 2011

Unique Partnership to Provide Guidance for Oncology Payers and Providers

April 1st 2010

The National Oncology Working Group (NOW) Initiative: Payer and Provider Collaborations in Oncology Benefits Management

Aileen M. Soper, BA C. E. (Gene) Reeder, RPh, PhD Loreen M. Brown, MSW Ana Stojanovska, BS Barbara J. Lennert, RN, BSN, MAOM

This article highlights the work of the National Oncology Working Group (NOW) Initiative.

...

179 180 181 182 183 184 >